Literature DB >> 8892879

Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication.

T Kim1, R A Mudry, C A Rexrode, V K Pathak.   

Abstract

Retroviruses mutate at a high rate in vivo during viral replication. Mutations may occur during proviral transcription by RNA polymerase II, during minus-strand DNA synthesis (RNA template) by viral reverse transcriptase, or during plus-strand DNA synthesis (DNA template) by reverse transcriptase. To determine the contributions of different stages of replication to the retroviral mutation rates, we developed a spleen necrosis virus-based in vivo system to selectively identify mutations occurring during the early stage (RNA transcription plus minus-strand synthesis) and the late stage (plus-strand synthesis plus DNA repair). A lacZalpha reporter gene was inserted into the long terminal repeat (LTR) of a spleen necrosis virus shuttle vector, and proviruses were recovered from infected cells as plasmids containing either one or both LTRs. Plasmids containing both LTRs generated a mutant phenotype only if the lacZalpha genes in both LTRs were mutated, which is most likely to occur during the early stage. Mutant phenotypes were identified from plasmids containing one LTR regardless of the stage at which the mutations occurred. Thus, mutant frequencies obtained after recovery of plasmids containing both LTRs or one LTR provided early-stage and total mutation rates, respectively. Analysis of 56,409 proviruses suggested that the retroviral mutation rates during the early and late stages of replication were equal or within twofold of each other. In addition, two mutants with A-to-G hypermutations were discovered, suggesting a role for mammalian double-stranded RNA adenosine deaminase enzyme in retroviral mutations. These experiments provide a system to selectively identify mutations in the early stage of retroviral replication and to provide upper and lower limits to the in vivo mutation rates during minus-strand and plus-strand synthesis, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892879      PMCID: PMC190828     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  A restriction enzyme cleavage map of Tn5 and location of a region encoding neomycin resistance.

Authors:  R A Jorgensen; S J Rothstein; W S Reznikoff
Journal:  Mol Gen Genet       Date:  1979

2.  Modification of retroviral RNA by double-stranded RNA adenosine deaminase.

Authors:  A M Hajjar; M L Linial
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

3.  Strategies of research for a vaccine against AIDS.

Authors:  M Essex
Journal:  Hist Philos Life Sci       Date:  1995       Impact factor: 1.205

4.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

5.  Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction.

Authors:  M A Martínez; M Sala; J P Vartanian; S Wain-Hobson
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

6.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

7.  Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae.

Authors:  L Gritz; J Davies
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

8.  Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors.

Authors:  S Watanabe; H M Temin
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

9.  Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications.

Authors:  S Parthasarathi; A Varela-Echavarría; Y Ron; B D Preston; J P Dougherty
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Viral dynamics in human immunodeficiency virus type 1 infection.

Authors:  X Wei; S K Ghosh; M E Taylor; V A Johnson; E A Emini; P Deutsch; J D Lifson; S Bonhoeffer; M A Nowak; B H Hahn
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

View more
  28 in total

1.  Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication.

Authors:  Q Dang; W S Hu
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.

Authors:  Michael E Abram; Andrea L Ferris; Wei Shao; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

Review 3.  Hepatitis C virus genetic variability and evolution.

Authors:  Natalia Echeverría; Gonzalo Moratorio; Juan Cristina; Pilar Moreno
Journal:  World J Hepatol       Date:  2015-04-28

4.  Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis.

Authors:  R R Bowman; W S Hu; V K Pathak
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference.

Authors:  W S Hu; E H Bowman; K A Delviks; V K Pathak
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer.

Authors:  Jean L Mbisa; Galina N Nikolenko; Vinay K Pathak
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 7.  HIV-1 reverse transcription.

Authors:  Wei-Shau Hu; Stephen H Hughes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

8.  RNA motifs mediating in vivo site-specific nonhomologous recombination in (+) RNA virus enforce in vitro nonhomologous crossovers with HIV-1 reverse transcriptase.

Authors:  M Figlerowicz; A Bibiłło
Journal:  RNA       Date:  2000-03       Impact factor: 4.942

Review 9.  Hepatitis C virus: Promising discoveries and new treatments.

Authors:  Juliana Cristina Santiago Bastos; Marina Aiello Padilla; Leonardo Cardia Caserta; Noelle Miotto; Aline Gonzalez Vigani; Clarice Weis Arns
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

10.  Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate.

Authors:  J G Julias; V K Pathak
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.